Price competition in pharmaceuticals : evidence from 1303 Swedish markets
Year of publication: |
2018
|
---|---|
Authors: | Granlund, David ; Bergman, Mats A. |
Published in: |
Journal of health economics. - Amsterdam [u.a.] : Elsevier, ISSN 0167-6296, ZDB-ID 625797-5. - Vol. 61.2018, p. 1-12
|
Subject: | Adjustment | Brand-name drugs | Dynamic | Generic drugs | Generic substitution | Pharmaceutical industry | Price competition | Reference price | Pharmaindustrie | Generika | Arzneimittel | Pharmaceuticals | Schweden | Sweden | Preiswettbewerb | Arzneimittelmarkt | Pharmaceutical market | Gesundheitskosten | Health care costs | Preis | Price | Preismanagement | Pricing strategy |
-
Endogenous versus exogenous generic reference pricing for pharmaceuticals
AntoƱanzas Villar, Fernando, (2017)
-
Implementing personalized medicine with asymmetric information on prevalence rates
AntoƱanzas Villar, Fernando, (2016)
-
Empirical evidence of risk penalties for NTI Drugs
Gentry, Elissa Philip, (2019)
- More ...
-
Bergman, Mats A., (2016)
-
Price competition in pharmaceuticals : evidence from 1303 Swedish markets
Granlund, David, (2017)
-
Reforming the Swedish pharmaceuticals market : consequences for costs per defined daily dose
Bergman, Mats A., (2016)
- More ...